[1]万 腾,吴晓凡,李 靖.血管介入栓塞术治疗动脉瘤性蛛网膜下腔出血疗效及对患者血清高迁移率族蛋白B1、血清可溶性细胞间黏附因子-1、可溶性血管细胞黏附因子-1的影响[J].陕西医学杂志,2025,54(1):80-83.[doi:DOI:10.3969/j.issn.1000-7377.2025.01.015]
　WAN Teng,WU Xiaofan,LI Jing.Effect of Vascular Interventional Embolization on Aneurysmal Subarachnoid Hemorrhage and Its Influence on Serum HMGB1,sICAM-1 and sVCAM-1[J].,2025,54(1):80-83.[doi:DOI:10.3969/j.issn.1000-7377.2025.01.015]
点击复制

血管介入栓塞术治疗动脉瘤性蛛网膜下腔出血疗效及对患者血清高迁移率族蛋白B1、血清可溶性细胞间黏附因子-1、可溶性血管细胞黏附因子-1的影响
分享到：

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
54
期数:
2025年1期
页码:
80-83
栏目:
临床研究
出版日期:
2025-01-05

文章信息/Info

Title:
Effect of Vascular Interventional Embolization on Aneurysmal Subarachnoid Hemorrhage and Its Influence on Serum HMGB1,sICAM-1 and sVCAM-1
作者:
万 腾; 吴晓凡; 李 靖
(淮安市第二人民医院神经外科,江苏 淮安 200230)
Author(s):
WAN Teng; WU Xiaofan; LI Jing
(Department of Neurosurgery,Huai'an Second People's Hospital,Huai'an 200230,China)
关键词:
血管介入栓塞术;  可溶性血管细胞黏附因子-1;  颅内动脉瘤夹闭术;  动脉瘤性蛛网膜下腔出血;  可溶性细胞间黏附因子-1;  高迁移率族蛋白 B1
Keywords:
Vascular interventional embolization;  Soluble vascular cell adhesion factor-1;  Intracranial aneurysm clipping;  Aneurysmal subarachnoid hemorrhage;  Soluble intercellular adhesion factor-1;  High mobility group protein B1
分类号:
R 743
DOI:
DOI:10.3969/j.issn.1000-7377.2025.01.015
文献标志码:
A
摘要:
目的:探讨血管介入栓塞术治疗动脉瘤性蛛网膜下腔出血(aSAH)的疗效及对血清高迁移率族蛋白 B1(HMGB1)、血清可溶性细胞间黏附因子-1(sICAM-1)、可溶性血管细胞黏附因子-1(sVCAM-1)的影响。方法:选择92例aSAH患者为研究目标,根据手术方法不同分为对照组(颅内动脉瘤夹闭术治疗)46例,观察组(血管介入栓塞术治疗)46例,比较两组手术前后免疫功能及sICAM-1、sVCAM-1、HMGB1水平变化,记录手术时间、并发症发生率、住院时间,并评估预后情况。结果:观察组手术时间、住院时间分别为(92.03±14.97)min、(18.73±4.41)d均短于对照组的手术时间(147.92±34.21)min,术后住院时间(23.35±4.15)d(均P<0.05); 术后观察组免疫功能高于对照组(P<0.05); 观察组术后HMGB1、sICAM-1、sVCAM-1水平低于对照组(均P<0.05); 对照组不良反应总发生率高于观察组(P<0.05); 对照组知期预后良好率低于观察组(P<0.05)。结论:血管介入栓塞术治疗aSAH手术耗时短、脑血管痉挛发生率低、免疫状态影响小,并可明降低血清HMGB1、sICAM-1、sVCAM-1水平。
Abstract:
Objective:To investigate the efficacy of interventional embolization in the treatment of aneurysmal Subarachnoid hemorrhage(aSAH)and its effect on serum HMGB1,sICAM-1 and sVCAM-1.Methods:92 patients with aSAH were selected as the research target.According to the different surgical methods,46 patients were divided into the control group(intracranial aneurysm clipping treatment)and the observation group(vascular intervention embolization treatment).The immune function and serum levels of sICAM-1,sVCAM-1 and HMGB1were compared between the two groups before and after treatment The incidence of complications,length of hospital stay,and evaluation of prognosis.Results:Observation group operation time,length of hospital stay(92.03±14.97)min,respectively(18.73 ±4.41)d of operation time is shorter than control group(147.92±34.21)min,postoperative length of hospital stay(23.35±4.15)d(all P<0.05).Postoperative observation group of immune function is better than the control group(all P<0.05).Postoperative observation group HMGB1,sICAM-1,sVCAM-1 level is lower than the control group(all P<0.05).The control rate was 47.82%(22/46)is lower than the observation group good prognosis good prognosis rate was 69.59%(32/46)(all P<0.05).The control group 17.39% of the total incidence of 34.78% higher than in observation group(all P<0.05).Conclusion:Vascular interventional embolization for the treatment of a SAH has the advantages of short surgical time,low incidence of cerebral vasospasm,minimal impact on immune status,and can significantly reduce serum levels of HMGB1,sICAM-1,and sVCAM-1.

参考文献/References:

[1] 魏康康.ET-1、sICAM-1及TBIL水平与颅内动脉瘤夹闭术后复发的相关性分析[J].保健医学研究与实践,2023,20(3):31-34.
[2] MAROTTA G,DE BERNARDO M,VITIELLO L,et al.Ocular ultrasonography to detect intracranial hypertension in subarachnoid hemorrhage patients[J].Neurocrit Care,2020,33(3):855-856.
[3] 李泽新,张贝贝.血清缺氧诱导因子-1α、前列腺素E2水平与动脉瘤性蛛网膜下腔出血关系及对脑血管痉挛的预测价值[J].陕西医学杂志,2023,52(2):141-144,191.
[4] 陈俊臣,任晓乐,李倩,等.解痉汤治疗动脉瘤性蛛网膜下腔出血后脑血管痉挛临床研究[J].陕西中医,2020,41(8):1055-1058.
[5] 赵立斌,贺红艳,武文兴,等.血浆NF-κB、sICAM-1、ET-1在动脉瘤性蛛网膜下腔出血血管痉挛诊断中的应用价值[J].中国实验诊断学,2021,25(2):165-168.
[6] 杨瑞林,杨永青,李博,等.奥拉西坦联合尼莫地平对自发性蛛网膜下腔出血患者血清IGF-1,sICAM-1及sVCAM-1水平的影响[J].现代生物医学进展,2016,38(24):4657-4660.
[7] 李栋,赵志远,翟延青,等.血管介入栓塞术治疗动脉瘤性蛛网膜下腔出血的疗效及对患者血管内皮功能的影响[J].山东医药,2023,63(4):53-55.
[8] 中华医学会神经病学分会.中国蛛网膜下腔出血诊治指南2019[J].中华神经科杂志,2019,52(12):1006-1021.
[9] 陈俊臣,任晓乐,李倩,等.解痉汤治疗动脉瘤性蛛网膜下腔出血后脑血管痉挛临床研究[J].陕西中医,2020,41(8):1055-1058.
[10] 王钢,雷超,温大平,等.低剖面可视化腔内支撑支架辅助弹簧圈栓塞术治疗急性期破裂颅内宽颈动脉瘤疗效研究[J].陕西医学杂志,2023,52(2):154-157.
[11] SAMUELS O B,SADAN O,FENG C,et al.Aneurysmal subarachnoid hemorrhage:Trends,outcomes,and predictions from a 15-year perspective of a single neurocritical care unit[J].Neurosurgery,2021,88(3):574-583.
[12] 李雄飞,胡伟,周明安,等.血管内介入栓塞术与显微外科动脉瘤夹闭术治疗颅内动脉瘤破裂的疗效对比研究[J].中西医结合心脑血管病杂志,2020,18(17):2909-2912.
[13] 孙腾飞,金虎,曹隆檬.远端缺血预处理预防急性冠状动脉综合征患者择期经皮冠状动脉介入术中无复流的临床研究[J].心脑血管病防治,2023,23(9):6-10,14.
[14] 舒波,出良钊,甘鸿川,等.早期血管内介入栓塞术治疗老年脑动脉瘤的临床疗效观察[J].神经疾病与精神卫生,2023,23(2):92-97.
[15] 张涛,孙含蓄,孙世远.颅内动脉瘤血管内介入栓塞术预后不良危险因素分析[J].河南外科学杂志,2023,29(1):78-80.
[16] 徐耀端,刘海川,白鹏.血管内介入栓塞和显微夹闭术对颅内动脉瘤患者血清MBP、IMA及TNF-α水平的影响[J].中国煤炭工业医学杂志,2022,25(3):324-328.
[17] 陈永军.动脉瘤介入栓塞术与颅内动脉瘤夹闭术治疗高分级动脉瘤性蛛网膜下腔出血的效果比较[J].中华肿瘤防治杂志,2018,31(S1):14-15,17.
[18] 史洁,汲蕊,管志玉,等.基于HMGB1-TLR2/TLR4-NF-κB通路探索氧化苦参碱对小鼠微小隐孢子虫感染的影响[J].中国血吸虫病防治杂志,2024,36(3):286-293.
[19] 张振祥,高守媛,栗延伟,等.HMGB1-TLR4介导的NF-κB信号通路在腺苷预处理保护脑缺血再灌注损伤中的作用[J].中国免疫学杂志,2024,40(3):491-496.
[20] 郑俏,狄岩,岳思恩,等.黄芪多糖调节HMGB1-RAGE信号通路对自身免疫性心肌炎大鼠心肌损伤的影响[J].中医药导报,2024,30(3):25-29,36.
[21] 侯睿,胡炜,董佩,等.糖尿病肾病患者血清ICAM-1 VCAM-1及CTRP9表达水平与冠脉血管钙化的关系[J].河北医学,2022,28(8):1279-1285.
[22] 张景鑫,常晓烨,王霏.芪冬颐心口服液对急性心肌梗死患者PCI术后心脏微血管功能及焦虑状态的影响[J].临床误诊误治,2023,36(10):133-138.
[23] 孟华,安松涛,张燕,等.补体C1q肿瘤坏死因子相关蛋白1通过激活p38信号通路增加内皮细胞黏附[J].中国动脉硬化杂志,2019,27(1):34-39.
[24] 李维国,申立波,李俊岭,等.介入栓塞术与手术夹闭法对动脉瘤性蛛网膜下腔出血患者免疫功能的影响[J].中国医师杂志,2018,20(7):1097-1099.
[25] 何强,许进.动脉瘤性蛛网膜下腔出血患者行介入栓塞术与夹闭术的对照研究[J].神经损伤与功能重建,2019,14(11):578-580.

备注/Memo

备注/Memo:
基金项目::江苏省自然科学基金资助项目(HD2022FE036)
更新日期/Last Update: 2025-01-06